Safety and efficacy of a novel anti-CD19 chimeric antigen receptor T cell product targeting a membrane-proximal domain of CD19 with fast on- and off-rates against non-Hodgkin lymphoma: a first-in-human study

Yunlin Zhang, Marco Ruella, Ositadimma Ugwuanyi et al.|Molecular Cancer|2023

Cited by 32